AHA GUIDELINES Bundle (free trial)

Hypertrophic Cardiomyopathy 2024

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1521559

Contents of this Issue

Navigation

Page 15 of 43

16 Treatment Figure 1. Recommended Evaluation and Testing for HCM HCM Suspected or Family History of HCM Diagnostic Testing (ECG, Imaging, Genetics) (See Figure 2 for details on genetic testing) YES NO Phenotype Negative Further clinical or genetic testing is not recommended (3: No Benefit) Family with known P/LP variant? (See Figure 2 for more detail) Reassess variant classification (1) 1 YES, or Unknown NO Patient has family variant? Variant downgraded to VUS Variant = P/LP * e interval may be extended, particularly in adult patients who remain stable aer multiple evaluations. 3 4 Screening ECG and echo (CMR if echo is inconclusive) at the intervals in Table 6 (1) 5

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Hypertrophic Cardiomyopathy 2024